Li Shan, Ye Lu, Xiaoli Zhu, Xu Cheng. In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells. // Current Pharmaceutical Analysis. – 2026. – DOI: 10.1016/j.cpan.2026.09.009. – URL: https://doi.org/10.1016/j.cpan.2026.09.009
Li Shan, Ye Lu, Xiaoli Zhu, & Xu Cheng (2026). In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells. Current Pharmaceutical Analysis. https://doi.org/10.1016/j.cpan.2026.09.009
Li Shan, et al. “In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells.” Current Pharmaceutical Analysis, 2026. doi:10.1016/j.cpan.2026.09.009.
@article{Shan2026,
title = {In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells},
author = {Shan, Li and Lu, Ye and Zhu, Xiaoli and Cheng, Xu},
journal = {Current Pharmaceutical Analysis},
year = {2026},
doi = {10.1016/j.cpan.2026.09.009},
url = {https://doi.org/10.1016/j.cpan.2026.09.009}
}